Search Results - Iris Lin
- Showing 1 - 10 results of 10
-
1
-
2
-
3
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study by Aarti A. Patel, Shannon Allen Ferrante, Iris Lin, Alex Z. Fu, Alicia K. Campbell, Arlene Tieng
Published in Rheumatology and Therapy (2023-07-01)Get full text
Article -
4
Real-world treatment patterns of patients with EGFR exon 20 insertion–mutated advanced NSCLC treated with amivantamab or mobocertinib after platinum-based chemotherapy: A multi-dat... by Alexander Spira, Dexter Waters, Tao Ran, Pratyusha Vadagam, Jinghua He, Julie Vanderpoel, Anjali Donnelly, Iris Lin
Published in Cancer Treatment and Research Communications (2025-01-01)Get full text
Article -
5
Ventral pallidum neurons projecting to the ventral tegmental area reinforce but do not invigorate reward-seeking behavior by Dakota Palmer, Christelle A. Cayton, Alexandra Scott, Iris Lin, Bailey Newell, Anika Paulson, Morgan Weberg, Jocelyn M. Richard
Published in Cell Reports (2024-01-01)Get full text
Article -
6
Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States by Jonathan I. Silverberg, Feifei Yang, Evo Alemao, Jing Zhao, Concetta Crivera, Hetal V. Patel, Iris Lin, Aaron R. Mangold
Published in JEADV Clinical Practice (2024-09-01)Get full text
Article -
7
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer by David Waterhouse, Iris Lin, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Jill Korsiak, Patrick Lefebvre, Pratyusha Vadagam, Dexter Waters
Published in Journal of Health Economics and Outcomes Research (2025-08-01)Get full text
Article -
8
P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH O... by Irina Murakhovskaya, Concetta Crivera, Ann Leon, Evo Alemao, Vamshi Ruthwik Anupindi, Mitch Dekoven, Victoria Divino, Iris Lin, Cathye Shu, Tarek Ebrahim
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors by Jessica A. Walsh, Iris Lin, Ruizhi Zhao, Natalie J. Shiff, Laura Morrison, Bruno Emond, Louise H. Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D. Chakravarty, Philip Mease
Published in Drugs - Real World Outcomes (2024-07-01)Get full text
Article -
10
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Regi... by Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Published in Rheumatology and Therapy (2023-08-01)Get full text
Article
